User profiles for Giorgia Massacci
Giorgia MassacciUniversity of Rome Tor Vergata Verified email at moleculargenetics.uniroma2.it Cited by 120 |
[HTML][HTML] The Cyclin-dependent kinase 1: more than a cell cycle regulator
G Massacci, L Perfetto, F Sacco - British Journal of Cancer, 2023 - nature.com
The Cyclin-dependent kinase 1, as a serine/threonine protein kinase, is more than a cell cycle
regulator as it was originally identified. During the last decade, it has been shown to carry …
regulator as it was originally identified. During the last decade, it has been shown to carry …
Metabolic reprogramming of fibro/adipogenic progenitors facilitates muscle regeneration
…, LL Petrilli, G Maiolatesi, G Massacci… - Life science …, 2020 - life-science-alliance.org
In Duchenne muscular dystrophy (DMD), the absence of the dystrophin protein causes a
variety of poorly understood secondary effects. Notably, muscle fibers of dystrophic individuals …
variety of poorly understood secondary effects. Notably, muscle fibers of dystrophic individuals …
[HTML][HTML] SCA-1 micro-heterogeneity in the fate decision of dystrophic fibro/adipogenic progenitors
The term micro-heterogeneity refers to non-genetic cell to cell variability observed in a bell-shaped
distribution of the expression of a trait within a population. The contribution of micro-…
distribution of the expression of a trait within a population. The contribution of micro-…
[HTML][HTML] Impact of FLT3-ITD location on cytarabine sensitivity in AML: a network-based approach
TO THE EDITOR 25-30% of younger adults with newly diagnosed acute myeloid leukemia (AML)
carry internal tandem duplications (ITDs) in the FLT3 gene [1]. ITD mutations regularly …
carry internal tandem duplications (ITDs) in the FLT3 gene [1]. ITD mutations regularly …
[HTML][HTML] The immunosuppressant drug azathioprine restrains adipogenesis of muscle Fibro/Adipogenic Progenitors from dystrophic mice by affecting AKT signaling
Fibro/Adipogenic Progenitors (FAPs) define a stem cell population playing a pro-regenerative
role after muscle damage. When removed from their natural niche, FAPs readily …
role after muscle damage. When removed from their natural niche, FAPs readily …
[HTML][HTML] A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patients
The insertion site of the internal tandem duplications (ITDs) in the FLT3 gene affects the
sensitivity to tyrosine kinase inhibitors (TKIs) therapy in acute myeloid leukemia (AML). Patients …
sensitivity to tyrosine kinase inhibitors (TKIs) therapy in acute myeloid leukemia (AML). Patients …
[HTML][HTML] Integrating patient-specific information into logic models of complex diseases: application to acute myeloid leukemia
High throughput technologies such as deep sequencing and proteomics are increasingly
becoming mainstream in clinical practice and support diagnosis and patient stratification. …
becoming mainstream in clinical practice and support diagnosis and patient stratification. …
[HTML][HTML] Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction
S Latini, V Venafra, G Massacci, V Bica, S Graziosi… - Elife, 2024 - elifesciences.org
Currently, the identification of patient-specific therapies in cancer is mainly informed by
personalized genomic analysis. In the setting of acute myeloid leukemia (AML), patient-drug …
personalized genomic analysis. In the setting of acute myeloid leukemia (AML), patient-drug …
[HTML][HTML] A resource for the network representation of cell perturbations caused by SARS-CoV-2 infection
The coronavirus disease 2019 (COVID-19) pandemic has caused more than 2.3 million
casualties worldwide and the lack of effective treatments is a major health concern. The …
casualties worldwide and the lack of effective treatments is a major health concern. The …
[HTML][HTML] Combining mass spectrometry-based phosphoproteomics with a network-based approach to reveal flt3-dependent mechanisms of chemoresistance
FLT3 mutations are the most frequently identified genetic alterations in acute myeloid
leukemia (AML) and are associated with poor clinical outcome, relapse and chemotherapeutic …
leukemia (AML) and are associated with poor clinical outcome, relapse and chemotherapeutic …